These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 21068703)
21. Botulinum toxin in the treatment of neurological disorders. Denislic M; Pirtosek Z; Vodusek DB; Zidar J; Meh D Ann N Y Acad Sci; 1994 Mar; 710():76-87. PubMed ID: 8154763 [TBL] [Abstract][Full Text] [Related]
22. [Botulinum toxin A in therapy of craniocervical dystonias and hemifacial spasm]. Thill R; Költringer P; Reisecker F; Maller J; Leblhuber F Acta Med Austriaca; 1991; 18(5):125-9. PubMed ID: 1796725 [TBL] [Abstract][Full Text] [Related]
23. [Treatment with botulinum toxin in blepharospasm]. Grandas F Arch Neurobiol (Madr); 1991; 54(5):206-9. PubMed ID: 1804034 [TBL] [Abstract][Full Text] [Related]
24. [Treatment with botulinum toxin in blepharospasm]. Grandas F Arch Neurobiol (Madr); 1991; 54 Suppl 3():40-3. PubMed ID: 1810207 [TBL] [Abstract][Full Text] [Related]
25. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A. Greene PE; Fahn S Mov Disord; 1993 Oct; 8(4):479-83. PubMed ID: 8232357 [TBL] [Abstract][Full Text] [Related]
27. Interventional neurology: treatment of neurological conditions with local injection of botulinum toxin. Brin MF Arch Neurobiol (Madr); 1991; 54(5):173-89. PubMed ID: 1804032 [No Abstract] [Full Text] [Related]
28. Interventional neurology: treatment of neurological conditions with local injection of botulinum toxin. Brin MF Arch Neurobiol (Madr); 1991; 54 Suppl 3():7-23. PubMed ID: 1810210 [No Abstract] [Full Text] [Related]
29. [Current status and prospects of medical therapy for dystonia]. Osawa M Rinsho Shinkeigaku; 2006 Nov; 46(11):967-9. PubMed ID: 17432235 [TBL] [Abstract][Full Text] [Related]
30. [Clinical application of botulinum toxin]. Mezaki T Brain Nerve; 2011 Jul; 63(7):785-94. PubMed ID: 21747149 [TBL] [Abstract][Full Text] [Related]
31. [A survey about the accessibility to botulinum toxin therapy for dystonia]. Mezaki T; Hayashi A; Nakase H; Hasegawa K No To Shinkei; 2006 Mar; 58(3):219-24. PubMed ID: 16629446 [TBL] [Abstract][Full Text] [Related]
32. [Indications for botulinum toxin in neurology]. Ghika J; Küntzer T; Regli F Rev Med Suisse Romande; 1994 Jun; 114(6):551-5. PubMed ID: 8047771 [No Abstract] [Full Text] [Related]
33. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects. Dutton JJ Surv Ophthalmol; 1996; 41(1):51-65. PubMed ID: 8827930 [TBL] [Abstract][Full Text] [Related]
35. The safety and tolerability of botulinum toxins for the treatment of cervical dystonia. Brashear A Expert Opin Drug Saf; 2005 Mar; 4(2):241-9. PubMed ID: 15794717 [TBL] [Abstract][Full Text] [Related]
36. Botulinum A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm. Berardelli A; Carta A; Stocchi F; Formica A; Agnoli A; Manfredi M Ital J Neurol Sci; 1990 Dec; 11(6):589-93. PubMed ID: 2081684 [TBL] [Abstract][Full Text] [Related]
37. Treatment of cervical dystonia (torticollis) in adults with botulinum A toxin. Metzer WS; Jenkins T J Ark Med Soc; 1992 Aug; 89(3):133-4. PubMed ID: 1517180 [TBL] [Abstract][Full Text] [Related]
39. [Own experience with botulinum treatment of dystonia]. Domzał T Neurol Neurochir Pol; 1995; 29(4):481-8. PubMed ID: 8544926 [TBL] [Abstract][Full Text] [Related]
40. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox. Badarny S; Susel Z; Honigman S Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]